Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Dunning

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|September 15, 2005
A model for immunological correlates of protectionAndrew J Dunning
Pharmaceutical Statistics|October 17, 2014
Control of type 1 error in a hybrid complete two-period vaccine efficacy trialAndrew J Dunning, John Reeves
BMC Medical Research Methodology|December 29, 2015
Some extensions in continuous models for immunological correlates of protectionAndrew J Dunning, Jennifer Kensler, Laurent Coudeville, et al.
BMC Medical Research Methodology|March 2, 2013
A threshold method for immunological correlates of protectionXuan Chen, Fabrice Bailleux, Kamal Desai, et al.
Vaccine|December 25, 2012
High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 seasonCarlos A DiazGranados, Andrew J Dunning, Emilia Jordanov, et al.
Clinical and Vaccine Immunology : CVI|January 15, 2016
Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy TrialAndrew J Dunning, Carlos A DiazGranados, Timothy Voloshen, et al.
Vaccine|July 19, 2015
Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailtyCarlos A DiazGranados, Andrew J Dunning, Corwin A Robertson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older AdultsCarlos A DiazGranados, Andrew J Dunning, Corwin A Robertson, et al.
Vaccine|July 28, 2015
Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccinesCarlos A DiazGranados, Corwin A Robertson, H Keipp Talbot, et al.
Open Forum Infectious Diseases|June 27, 2018
Gastrointestinal Events in High-Dose vs Standard-Dose Influenza Vaccine RecipientsH Keipp Talbot, Andrew J Dunning, Corwin A Robertson, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|September 15, 2005
A model for immunological correlates of protectionAndrew J Dunning
Pharmaceutical Statistics|October 17, 2014
Control of type 1 error in a hybrid complete two-period vaccine efficacy trialAndrew J Dunning, John Reeves
BMC Medical Research Methodology|December 29, 2015
Some extensions in continuous models for immunological correlates of protectionAndrew J Dunning, Jennifer Kensler, Laurent Coudeville, et al.
BMC Medical Research Methodology|March 2, 2013
A threshold method for immunological correlates of protectionXuan Chen, Fabrice Bailleux, Kamal Desai, et al.
Vaccine|December 25, 2012
High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 seasonCarlos A DiazGranados, Andrew J Dunning, Emilia Jordanov, et al.
Clinical and Vaccine Immunology : CVI|January 15, 2016
Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy TrialAndrew J Dunning, Carlos A DiazGranados, Timothy Voloshen, et al.
Vaccine|July 19, 2015
Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailtyCarlos A DiazGranados, Andrew J Dunning, Corwin A Robertson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older AdultsCarlos A DiazGranados, Andrew J Dunning, Corwin A Robertson, et al.
Vaccine|July 28, 2015
Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccinesCarlos A DiazGranados, Corwin A Robertson, H Keipp Talbot, et al.
Open Forum Infectious Diseases|June 27, 2018
Gastrointestinal Events in High-Dose vs Standard-Dose Influenza Vaccine RecipientsH Keipp Talbot, Andrew J Dunning, Corwin A Robertson, et al.
Pageof 2